Involvement of the multidrug resistance transporters in cisplatin-induced neuropathy in rats. Comparison with the chronic constriction injury model and monoarthritic rats

European Journal of Pharmacology

Volumn 544, Issue 1-3, 2006, Pages 49-57

  Balayssac, David ^a,b   Cayre, Anne ^a,c,e   Authier, Nicolas ^a,b   Ling, Bing ^a   Maublant, Jean ^c,d   Eschalier, Alain ^a,b   Penault Llorca, Frédérique ^a,c,d   Coudore, François ^a,b  

^a INSERM   (France)

^b UNIVERSITY HOSPITAL OF CLERMONT FERRAND   (France)

^c CENTRE JEAN PERRIN   (France)

^d UNIVERSITÉ CLERMONT AUVERGNE   (France)

^e Institut Universitaire de Technologie   (France)

Author keywords

Cisplatin; mdr1a; mdr1b; Mononeuropathy; mrp2; Neuropathy

Indexed keywords

CISPLATIN; MULTIDRUG RESISTANCE PROTEIN;

ANIMAL MODEL; ARTICLE; BRAIN; GENE EXPRESSION; MALE; MONARTHRITIS; NERVOUS TISSUE; NEUROPATHY; NEUROTOXICITY; NONHUMAN; PERIPHERAL NERVE INJURY; PRIORITY JOURNAL; RAT; SPINAL CORD; SPINAL GANGLION;

EID: 33746622427     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2006.06.055     Document Type: Article

References (38)

1. Authier N., Gillet J.P., Fialip J., Eschalier A., and Coudore F. An animal model of nociceptive peripheral neuropathy following repeated cisplatin injections. Exp. Neurol. 182 (2003) 12-20
2. Balayssac D., Cayre A., Authier N., Bourdu S., Penault-Llorca F., Gillet J.P., Maublant J., Eschalier A., and Coudore F. Patterns of P-glycoprotein activity in the nervous system during vincristine-induced neuropathy in rats. J. Peripher. Nerv. Syst. 10 (2005) 301-310
3. Bennett G.J., and Xie Y.K. A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man. Pain 33 (1988) 87-107
4. Butler S.H., Godefroy F., Besson J.M., and Weil-Fugazza J. A limited arthritic model for chronic pain studies in the rat. Pain 48 (1992) 73-81
5. Buyse M., Radeva G., Bado A., and Farinotti R. Intestinal inflammation induces adaptation of P-glycoprotein expression and activity. Biochem. Pharmacol. 69 (2005) 1745-1754
6. Cherrington N.J., Hartley D.P., Li N., Johnson D.R., and Klaassen C.D. Organ distribution of multidrug resistance proteins 1, 2, and 3 (Mrp1, 2, and 3) mRNA and hepatic induction of Mrp3 by constitutive androstane receptor activators in rats. J. Pharmacol. Exp. Ther. 300 (2002) 97-104
7. Croop J.M., Raymond M., Haber D., Devault A., Arceci R.J., Gros P., and Housman D.E. The three mouse multidrug resistance (mdr) genes are expressed in a tissue-specific manner in normal mouse tissues. Mol. Cell. Biol. 9 (1989) 1346-1350
8. Dagenais C., Graff C.L., and Pollack G.M. Variable modulation of opioid brain uptake by P-glycoprotein in mice. Biochem. Pharmacol. 67 (2004) 269-276
9. Demeule M., Brossard M., and Beliveau R. Cisplatin induces renal expression of P-glycoprotein and canalicular multispecific organic anion transporter. Am. J. Physiol. 277 (1999) 832-840
10. Felix R.A., and Barrand M.A. P-glycoprotein expression in rat brain endothelial cells: evidence for regulation by transient oxidative stress. J. Neurochem. 80 (2002) 64-72
11. Fernandez C., Buyse M., German-Fattal M., and Gimenez F. Influence of the pro-inflammatory cytokines on P-glycoprotein expression and functionality. J. Pharm. Pharmacol. Sci. 7 (2004) 359-371
12. Goralski K.B., Hartmann G., Piquette-Miller M., and Renton K.W. Downregulation of mdr1a expression in the brain and liver during CNS inflammation alters the in vivo disposition of digoxin. Br. J. Pharmacol. 139 (2003) 35-48
13. Grubbs F. Procedures for detecting outlying observations in samples. Technometrics 11 (1969) 1-21
14. Lee C.H. Induction of P-glycoprotein mRNA transcripts by cycloheximide in animal tissues: evidence that class I Pgp is transcriptionally regulated whereas class II Pgp is post-transcriptionally regulated. Mol. Cell. Biochem. 216 (2001) 103-110
15. Lee H.L., Lee K.M., Son S.J., Hwang S.H., and Cho H.J. Temporal expression of cytokines and their receptors mRNAs in a neuropathic pain model. NeuroReport 15 (2004) 2807-2811
16. Letrent S.P., Pollack G.M., Brouwer K.R., and Brouwer K.L. Effect of GF120918, a potent P-glycoprotein inhibitor, on morphine pharmacokinetics and pharmacodynamics in the rat. Pharm. Res. 15 (1998) 599-605
17. Loscher W., and Potschka H. Role of multidrug transporters in pharmacoresistance to antiepileptic drugs. J. Pharmacol. Exp. Ther. 301 (2002) 7-14
18. Lotsch J., Schmidt R., Vetter G., Schmidt H., Niederberger E., Geisslinger G., and Tegeder I. Increased CNS uptake and enhanced antinociception of morphine-6-glucuronide in rats after inhibition of P-glycoprotein. J. Neurochem. 83 (2002) 241-248
19. Maher J.M., Slitt A.L., Cherrington N.J., Cheng X., and Klaassen C.D. Tissue distribution and hepatic and renal ontogeny of the Multidrug Resistance-associated Protein (MRP) family in mice. Drug Metab. Dispos. 33 (2005) 947-955
20. Masuyama H., Suwaki N., Tateishi Y., Nakatsukasa H., Segawa T., and Hiramatsu Y. The pregnane X receptor regulates gene expression in a ligand- and promoter-selective fashion. Mol. Endocrinol. 19 (2005) 1170-1180
21. Maublant J.C., Gachon P., and Moins N. Hexakis (2-methoxy isobutylisonitrile) technetium-99m and thallium-201 chloride: uptake and release in cultured myocardial cells. J. Nucl. Med. 29 (1988) 48-54
22. Maublant J.C., de Latour M., Mestas D., Clemenson A., Charrier S., Feillel V., Le Bouedec G., Kaufmann P., Dauplat J., and Veyre A. Technetium-99m-sestamibi uptake in breast tumor and associated lymph nodes. J. Nucl. Med. 37 (1996) 922-925
23. McDonald E.S., Randon K.R., Knight A., and Windebank A.J. Cisplatin preferentially binds to DNA in dorsal root ganglion neurons in vitro and in vivo: a potential mechanism for neurotoxicity. Neurobiol. Dis. 18 (2005) 305-313
24. Miller D.S., Nobmann S.N., Gutmann H., Toeroek M., Drewe J., and Fricker G. Xenobiotic transport across isolated brain microvessels studied by confocal microscopy. Mol. Pharmacol. 58 (2000) 1357-1367
25. Nies A.T., Jedlitschky G., Konig J., Herold-Mende C., Steiner H.H., Schmitt H.P., and Keppler D. Expression and immunolocalization of the multidrug resistance proteins, MRP1-MRP6 (ABCC1-ABCC6), in human brain. Neuroscience 129 (2004) 349-360
26. Ohga T., Uchiumi T., Makino Y., Koike K., Wada M., Kuwano M., and Kohno K. Direct involvement of the Y-box binding protein YB-1 in genotoxic stress-induced activation of the human multidrug resistance 1 gene. J. Biol. Chem. 273 (1998) 5997-6000
27. Piwnica-Worms D., Chiu M.L., Budding M., Kronauge J.F., Kramer R.A., and Croop J.M. Functional imaging of multidrug-resistant P-glycoprotein with an organotechnetium complex. Cancer Res. 53 (1993) 977-984
28. Potschka H., Fedrowitz M., and Loscher W. Multidrug resistance protein MRP2 contributes to blood-brain barrier function and restricts antiepileptic drug activity. J. Pharmacol. Exp. Ther. 306 (2003) 124-131
29. Quasthoff S., and Hartung H.P. Chemotherapy-induced peripheral neuropathy. J. Neurol. 249 (2002) 9-17
30. Randall L.O., and Selitto J.J. A method for measurement of analgesic activity on inflamed tissue. Arch. Int. Pharmacodyn. Ther. 111 (1957) 409-419
31. Schinkel A.H., and Jonker J.W. Mammalian drug efflux transporters of the ATP binding cassette (ABC) family: an overview. Adv. Drug Deliv. Rev. 55 (2003) 3-29
32. Schondorf T., Neumann R., Benz C., Becker M., Riffelmann M., Gohring U.J., Sartorius J., von Konig C.H., Breidenbach M., Valter M.M., Hoopmann M., Di Nicolantonio F., and Kurbacher C.M. Cisplatin, doxorubicin and paclitaxel induce mdr1 gene transcription in ovarian cancer cell lines. Recent Results Cancer Res. 161 (2003) 111-116
33. Steeghs N., de Jongh F.E., Sillevis Smitt P.A., and van den Bent M.J. Cisplatin-induced encephalopathy and seizures. Anticancer Drugs 14 (2003) 443-446
34. Stefansky W. Rejecting outliers in factorial designs. Technometrics 14 (1972) 469-479
35. Sukhai M., and Piquette-Miller M. Regulation of the multidrug resistance genes by stress signals. J. Pharm. Pharmacol. Sci. 3 (2000) 268-280
36. Uhr M., Grauer M.T., and Holsboer F. Differential enhancement of antidepressant penetration into the brain in mice with abcb1ab (mdr1ab) P-glycoprotein gene disruption. Biol. Psychiatry 54 (2003) 840-846
37. Utsunomiya K., Ballinger J.R., Piquette-Miller M., Rauth A.M., Tang W., Su Z.F., and Ichise M. Comparison of the accumulation and efflux kinetics of technetium-99m sestamibi and technetium-99m tetrofosmin in an MRP-expressing tumour cell line. Eur. J. Nucl. Med. 27 (2000) 1786-1792
38. Xu C., Li C.Y., and Kong A.N. Induction of phase I, II and III drug metabolism/transport by xenobiotics. Arch. Pharm. Res. 28 (2005) 249-268